The binding of PD1 ligand (PDL1), present on cancer cells or other non-malignant cells within the immune system, to PD1 on cytotoxic T-cell, leads to T-cell inhibition rendering the cancer cell invisible to the immune system. Here, CD274 is linked to cancer.